← Open Payments lookup

JASJIT SINGH: Open Payments

NPI 1265466197 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$169,239 in 297 payments from 16 companies in 2025. Trend: 2023 $55,460 · 2024 $66,579 · 2025 $169,239

Speaker / faculty: $89,232Honoraria: $45,225Travel & lodging: $17,024Consulting: $13,375Food & beverage: $4,349Education: $35
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)90$60,196
Axsome Therapeutics, Inc.59$49,310
E.R. Squibb & Sons, L.L.C.51$38,362
Alkermes, Inc.45$20,318
Neurocrine BioSciences, Inc.12$202
Janssen Pharmaceuticals, Inc4$154
Collegium Pharmaceutical, Inc.7$135
Teva Pharmaceuticals USA, Inc.6$114
Supernus Pharmaceuticals, Inc.4$87
Takeda Pharmaceuticals U.S.A., Inc.4$76

Products named: CAPLYTA, Auvelity, COBENFY, LYBALVI, ARISTADA, INGREZZA, Jornay PM, AUSTEDO XR.

Industry payments across LA — which companies pay providers there.